期刊档案 · Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Pharmaceutical Fronts
ISSN 2628-5088 · eISSN 2628-5096 · Georg Thieme Verlag KG · Germany
Pharmaceutical Fronts 影响因子 0.8(官网公布),钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 15 周,2025 年发文 35 篇,Scopus 收录,期刊官网显示已更换出版社。
期刊官网显示已更换出版社:10.1055/s-00050442 Note: The Arab Journal of Interventional Radiology, the official journal of Pan Arab Interventional Radiology Society (PAIRS), has transferred to a new publisher. Please see the Society website for mo... 原文 ↗出版商官网 ·
研究范围
研究范围与定位
Pharmaceutical Fronts 由 Georg Thieme Verlag KG 出版。按 OpenAlex 近年发文统计,该刊主要发表 Innovative Microfluidic and Catalytic Techniques Innovation、Drug Solubulity and Delivery Systems、Chemical Synthesis and Analysis 等主题的论文,这 3 个主题约占 22.4%。(根据 OpenAlex 主题统计与中科院分区数据生成)
Pharmaceutical Fronts is an international peer-reviewed journal focusing on the rapid and high-quality dissemination of the latest breakthroughs in pharmaceutical development across major scientific and engineering disciplines. It is an affiliated journal of the Chinese Journal of Pharmaceuticals (EI Compendex), which was founded in 1970, and sponsored by Shanghai Institute of Pharmaceutical Industry, Chinese Pharmaceutical Association and China Pharmaceutical Industry Association.The journal is delivering the ultimate reader experience with an innovative manuscript acquisition and review process focusing on information density, utility, and reliability. Its aims to cover original research as well as high quality reviews in medicinal chemistry, process development, and technological innovations for both laboratory and production settings. We will remain agile towards reader feedback and seek to provide a unique service to the global scientific and industrial community in the quest for better medicines and better ways to make them for patients across the world.Publishing 4 times a year in March, June, September, and December, Pharmaceutical Fronts includes significant original research articles as well as high quality reviews, commentaries and short communications in the following areas:Drug & Synthesis TechnologyAsymmetric Catalysis and Green ChemistryMedicinal ChemistryBiopharmaceuticalsPharmaceutical Sciences and Formulation TechnologyAnalytical SciencesEngineering InnovationsProcess Safety and Regulatory Sciences
摘自期刊官网 Aims & Scope
研究方向(LetPub):Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
主编 Girija Prasad RathThe出版商官网
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Innovative Microfluidic and Catalytic Techniques InnovationEngineering8.2%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.1%
- Chemical Synthesis and AnalysisBiochemistry, Genetics and Molecular Biology7.1%
- Computational Drug Discovery MethodsComputer Science6.6%
- Chemical Synthesis and ReactionsChemistry5.1%
- Synthesis and biological activityChemistry4.1%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.1%
- Nanoparticle-Based Drug DeliveryMaterials Science3.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
ScopusDOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
期刊官网自述收录
ESCICAS出版商官网
其他:EBSCO、ProQuest
期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子(出版商公布)
- 0.8出版商官网 ·
- CiteScore 2026-06
- 2.3LetPub ·
- CiteScore(出版商公布)
- 2.3出版商官网 ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 21OpenAlex ·
- 两年平均被引
- 1.2OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 223 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 25 | 25 | 4 |
| 2025 | 35 | 35 | 25 |
| 2024 | 37 | 37 | 87 |
| 2023 | 38 | 38 | 281 |
| 2022 | 32 | 32 | 183 |
| 2021 | 25 | 25 | 91 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度(社区反馈)
- 15 WeeksLetPub ·
- 投稿到发表(期刊自报)
- 约 15 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY | |
| LetPub | 无文章处理费 | 有 | — | |
| 出版商官网 | 有,金额未公布 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
接收的文章类型4 种
- commentariesincludes significant original research articles as well as high quality reviews, commentaries and short communications未说明篇幅
- original research articlesincludes significant original research articles as well as high quality reviews, commentaries and short communications未说明篇幅
- reviewsincludes significant original research articles as well as high quality reviews, commentaries and short communications未说明篇幅
- short communicationsincludes significant original research articles as well as high quality reviews, commentaries and short communications未说明篇幅
官网政策摘录作者资格、同行评审
- 作者资格
ICMJE recommendations required 模型摘要
Pharmaceutical Fronts requires that authors follow the ICMJE (International Committee of Medical Journal Editors) recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.
原文 ↗出版商官网 ·- 同行评审
Peer review described in aims and scope text. 模型摘要
Methods of Information in Medicine publishes international, peer-reviewed, original research articles, reviews, editorials, and letters to the editor.
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Georg Thieme Verlag KG
- 出版国家或地区
- Germany
- 出版语言
- English
- ISSN
- 2628-5088
- 电子版 ISSN
- 2628-5096
- 学会 / 主办单位
- Indian Society of Neuroanaesthesiology and Critical Care
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
常见问题
关于 Pharmaceutical Fronts 的常见问题
Pharmaceutical Fronts 的影响因子是多少?
期刊官网公布的影响因子为 0.8,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 2.3,h-index 为 13。
Pharmaceutical Fronts 的审稿周期多长?
投稿社区反馈的平均审稿速度为约 15 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Pharmaceutical Fronts 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Pharmaceutical Fronts 被 Scopus、DOAJ 收录。期刊官网自述还被 ESCI、CAS 收录,该清单未与各数据库逐一核对。
Pharmaceutical Fronts 是开放获取期刊吗?版面费多少?
Pharmaceutical Fronts 为钻石开放获取(无 APC)。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。